Bioxcel Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.23

-0.11 (-8.21%)

As of Apr 1, 3:51 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 82%

Hold 1 9%

Sell 1 9%

Price Target

Analyst Price Target +1,685.4% upside

Low Target $14.05

Average Target $21.96

High Target $26.87

Current Price $1.23

Current
$1.23

Target
$21.96

$14.05 $21.96 avg $26.87

Scenario Analysis

Bear Case

$14.05

1,042.3%

Low target

Base Case

$21.96

+1,685.4%

Avg target

Bull Case

$26.87

+2,084.6%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$8.08

-84.8% from high

52-Week Low

$1.17

+5.1% from low

Target vs 52W High

$21.96

+171.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%